Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4‐34 usage in mucosa‐associated lymphoid tissue lymphoma

Both antigenic drive and genetic change play critical roles in the development of mucosa‐associated lymphoid tissue (MALT) lymphoma, but neither alone is sufficient for malignant transformation, and lymphoma development critically depends on their cooperation. However, which of these different events concur and how they cooperate in MALT lymphomagenesis is totally unknown. To explore this, we investigated somatic mutations of 17 genes and immunoglobulin heavy chain variable region (IGHV) usage in 179 MALT lymphomas from various sites. We showed that: (1) there was a significant association between the biased usage of IGHV4‐34 (binds to the carbohydrate I/i antigens) and inactivating mutation of TNFAIP3 [encoding a global negative regulator of the canonical nuclear factor‐κB (NF‐κB) pathway] in ocular adnexal MALT lymphoma; (2) IGHV1‐69 was significantly overrepresented (54%) in MALT lymphoma of the salivary gland, but was not associated with mutation in any of the 17 genes investigated; and (3) MALT lymphoma lacked mutations that are frequently seen in other B‐cell lymphomas characterized by constitutive NF‐κB activities, including mutations in CD79B, CARD11, MYD88, TNFRSF11A, and TRAF3. Our findings show, for the first time, a significant association between biased usage of autoreactive IGHV and somatic mutation of NF‐κB regulators in MALT lymphoma, arguing for their cooperation in sustaining chronic B‐cell receptor signalling and driving oncogenesis in lymphoma development. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  K. Stamatopoulos,et al.  Antigen receptor stereotypy in chronic lymphocytic leukemia , 2017, Leukemia.

[2]  J. Delabie,et al.  Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity , 2016, Haematologica.

[3]  M. Du.  MALT lymphoma: A paradigm of NF-κB dysregulation. , 2016, Seminars in cancer biology.

[4]  Fleur S. van de Bovenkamp,et al.  The Emerging Importance of IgG Fab Glycosylation in Immunity , 2016, The Journal of Immunology.

[5]  R. Bende,et al.  Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity , 2016, Haematologica.

[6]  L. Staudt,et al.  Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens , 2015, Proceedings of the National Academy of Sciences.

[7]  David Kipling,et al.  Ageing of the B-cell repertoire , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[8]  Kim Brugger,et al.  Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing. , 2015, The Journal of molecular diagnostics : JMD.

[9]  J. Martinez-Climent,et al.  KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype , 2014, Leukemia.

[10]  Paul S. Meltzer,et al.  High prevalence of MAP2K1 mutations in variant and IGHV4-34 expressing hairy-cell leukemia , 2013, Nature Genetics.

[11]  R. Cummings,et al.  Molecular Basis of 9G4 B Cell Autoreactivity in Human Systemic Lupus Erythematosus , 2013, The Journal of Immunology.

[12]  M. Du,et al.  Distinct involvement of NF‐κB regulators by somatic mutation in ocular adnexal malt lymphoma , 2013, British journal of haematology.

[13]  Xiong-zeng Zhu,et al.  A20 inactivation in ocular adnexal MALT lymphoma , 2012, Haematologica.

[14]  K. Stamatopoulos,et al.  Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity , 2012, Leukemia.

[15]  M. Kersten,et al.  Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment , 2012, Leukemia.

[16]  F. Berger,et al.  Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. , 2012, Leukemia.

[17]  I. Lossos,et al.  Biased Use of the IGHV4 Family and Evidence for Antigen Selection in Chlamydophila psittaci-Negative Ocular Adnexal Extranodal Marginal Zone Lymphomas , 2011, PloS one.

[18]  G. van Loo,et al.  The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. , 2009, Trends in immunology.

[19]  W. Erber,et al.  A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology , 2007, British journal of haematology.

[20]  D. de Jong,et al.  Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity , 2005, The Journal of experimental medicine.

[21]  B. Sutton,et al.  Evidence for Involvement of a Hydrophobic Patch in Framework Region 1 of Human V4-34-Encoded Igs in Recognition of the Red Blood Cell I Antigen1 , 2002, The Journal of Immunology.

[22]  K. Stamatopoulos,et al.  Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation , 2012, Leukemia.